| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Common Stock | Options Exercise | $750,515 | +29,317 | +44% | $25.60 | 96,197 | 26 Feb 2022 | Direct | F1 |
| transaction | PFE | Common Stock | Tax liability | $358,425 | -7,511 | -7.8% | $47.72 | 88,686 | 26 Feb 2022 | Direct | F2, F3 |
| transaction | PFE | Common Stock | Tax liability | $693,160 | -13,688 | -15% | $50.64 | 74,998 | 26 Feb 2022 | Direct | F4, F5 |
| holding | PFE | Common Stock | 5,767 | 26 Feb 2022 | By Rule 16b-3 Plan |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Stock Appreciation Rights | Options Exercise | $0 | -29,317 | -100% | $0.000000* | 0 | 26 Feb 2022 | Common Stock | 29,317 | $25.60 | Direct |
| Id | Content |
|---|---|
| F1 | The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
| F2 | The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
| F3 | Price is the closing price of Pfizer common stock on February 25, 2022. |
| F4 | The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). |
| F5 | Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |